Up to date by: David C. Dugdale, III, MD, Professor of Drugs, Division of Basic Drugs, Division of Drugs, College of Washington Faculty of Drugs. Additionally reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial staff. Editorial replace 11/03/2020.
January 2021 Print this issue Ways to Improve Your Well-Being Have you been feeling more stressed than usual? Many people are during these challenging times. The COVID-19 pandemic has many people feeling overwhelmed. Everyone feels stress sometimes. It’s a natural […]
March 19, 2019, by NCI Staff PET scan of a tumor in the right kidney (arrows). Credit: Onco Targets Ther Feb 2014. doi: 10.2147/OTT.S58089. CC-BY 3.0 On April 19, 2019, the Food and Drug Administration approved pembrolizumab (Keytruda) in combination with axitinib (Inlyta) for the initial treatment of people with advanced kidney cancer. The approval […]
New Options for People with Advanced Aortic Stenosis One important reason to track any possible valve disease-related symptoms and get regular check-ups – especially as we age – is to ensure that any developing valve problems can be fixed at the right time. Unfortunately many people who need heart valve surgery simply do not get diagnosed […]